Eduard J Beck

Summary

Affiliation: Joint United Nations Programme on HIV/AIDS
Country: Switzerland

Publications

  1. ncbi Viewpoint: a pragmatic approach to constructing a minimum data set for care of patients with HIV in developing countries
    William M Tierney
    Indiana University School of Medicine, Indianapolis, IN 46202, USA
    J Am Med Inform Assoc 13:253-60. 2006
  2. ncbi Lower healthcare costs associated with the use of a single-pill ARV regimen in the UK, 2004-2008
    Eduard J Beck
    NPMS HHC CIC, Coordinating and Analytic Centre, London, United Kingdom
    PLoS ONE 7:e47376. 2012
  3. ncbi Counting the cost of not costing HIV health facilities accurately: pay now, or pay more later
    Eduard J Beck
    Office of the Deputy Director, Programme Branch, UNAIDS Secretariat, Geneva, Switzerland
    Pharmacoeconomics 30:887-902. 2012
  4. ncbi The cost-effectiveness of early access to HIV services and starting cART in the UK 1996-2008
    Eduard J Beck
    NPMS HHC CIC, Coordinating and Analytic Centre, London, United Kingdom
    PLoS ONE 6:e27830. 2011
  5. ncbi Modeling the cost-effectiveness of health programs: HIV testing and early treatment in the USA
    Eduard J Beck
    Health Services Research Unit, Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK
    Future Microbiol 6:725-9. 2011
  6. ncbi Cost-effectiveness of early treatment with first-line NNRTI-based HAART regimens in the UK, 1996-2006
    Eduard J Beck
    NPMS HHC Coordinating and Analytic Centre, London, United Kingdom
    PLoS ONE 6:e20200. 2011
  7. ncbi Protecting HIV information in countries scaling up HIV services: a baseline study
    Eduard J Beck
    Programme Branch, UNAIDS, Geneva, Switzerland
    J Int AIDS Soc 14:6. 2011
  8. ncbi The cost of treatment and care for people living with HIV infection: implications of published studies, 1999-2008
    Eduard J Beck
    UNAIDS Secretariat, Geneva, Switzerland
    Curr Opin HIV AIDS 5:215-24. 2010
  9. ncbi Why and how to monitor the cost and evaluate the cost-effectiveness of HIV services in countries
    Eduard J Beck
    Evidence, Monitoring and Policy Department, UNAIDS, Geneva, Switzerland
    AIDS 22:S75-85. 2008
  10. ncbi Treatment outcome and cost-effectiveness of different highly active antiretroviral therapy regimens in the UK (1996-2002)
    E J Beck
    NPMS HHC Coordinating and Analytic Centre, UK
    Int J STD AIDS 19:297-304. 2008

Collaborators

Detail Information

Publications18

  1. ncbi Viewpoint: a pragmatic approach to constructing a minimum data set for care of patients with HIV in developing countries
    William M Tierney
    Indiana University School of Medicine, Indianapolis, IN 46202, USA
    J Am Med Inform Assoc 13:253-60. 2006
    ..The proposed minimum data set will evolve over time as funding increases, care protocols change, and additional tests and treatments become available for HIV-infected patients in developing countries...
  2. ncbi Lower healthcare costs associated with the use of a single-pill ARV regimen in the UK, 2004-2008
    Eduard J Beck
    NPMS HHC CIC, Coordinating and Analytic Centre, London, United Kingdom
    PLoS ONE 7:e47376. 2012
    ....
  3. ncbi Counting the cost of not costing HIV health facilities accurately: pay now, or pay more later
    Eduard J Beck
    Office of the Deputy Director, Programme Branch, UNAIDS Secretariat, Geneva, Switzerland
    Pharmacoeconomics 30:887-902. 2012
    ....
  4. ncbi The cost-effectiveness of early access to HIV services and starting cART in the UK 1996-2008
    Eduard J Beck
    NPMS HHC CIC, Coordinating and Analytic Centre, London, United Kingdom
    PLoS ONE 6:e27830. 2011
    ..Few studies have calculated the use, cost and cost-effectiveness of routine treatment and care before starting cART and starting cART above and below CD4 200 cells/mm3...
  5. ncbi Modeling the cost-effectiveness of health programs: HIV testing and early treatment in the USA
    Eduard J Beck
    Health Services Research Unit, Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK
    Future Microbiol 6:725-9. 2011
    ..of an expanded screening and treatment program in the USA but how good was their model, how can modeling exercises assist policy-makers in answering these difficult questions and what are some of the broader implications?..
  6. ncbi Cost-effectiveness of early treatment with first-line NNRTI-based HAART regimens in the UK, 1996-2006
    Eduard J Beck
    NPMS HHC Coordinating and Analytic Centre, London, United Kingdom
    PLoS ONE 6:e20200. 2011
    ..Calculate time to first-line treatment failure, annual cost and cost-effectiveness of NNRTI versus PIboosted first-line HAART regimens in the UK, 1996-2006...
  7. ncbi Protecting HIV information in countries scaling up HIV services: a baseline study
    Eduard J Beck
    Programme Branch, UNAIDS, Geneva, Switzerland
    J Int AIDS Soc 14:6. 2011
    ..We set out to assess the extent that countries scaling up HIV services have developed and implemented guidelines to protect the confidentiality and security of HIV information...
  8. ncbi The cost of treatment and care for people living with HIV infection: implications of published studies, 1999-2008
    Eduard J Beck
    UNAIDS Secretariat, Geneva, Switzerland
    Curr Opin HIV AIDS 5:215-24. 2010
    ..Articles were identified using specific databases and scored, based on explicit criteria relating to the services covered, utilization data, cost data used and quality of the study...
  9. ncbi Why and how to monitor the cost and evaluate the cost-effectiveness of HIV services in countries
    Eduard J Beck
    Evidence, Monitoring and Policy Department, UNAIDS, Geneva, Switzerland
    AIDS 22:S75-85. 2008
    ..It also summarizes global initiatives that enable countries to develop their own HIV monitoring and evaluation systems and to generate relevant, robust and up-to-date strategic information...
  10. ncbi Treatment outcome and cost-effectiveness of different highly active antiretroviral therapy regimens in the UK (1996-2002)
    E J Beck
    NPMS HHC Coordinating and Analytic Centre, UK
    Int J STD AIDS 19:297-304. 2008
    ....
  11. ncbi Rising population cost for treating people living with HIV in the UK, 1997-2013
    Sundhiya Mandalia
    NPMS HHC Coordinating and Analytic Centre, London, United Kingdom
    PLoS ONE 5:e15677. 2010
    ..The number of people living with HIV (PLHIV) is increasing in the UK. This study estimated the annual population cost of providing HIV services in the UK, 1997-2006 and projected them 2007-2013...
  12. ncbi National adult antiretroviral therapy guidelines in resource-limited countries: concordance with 2003 WHO guidelines?
    Eduard J Beck
    HIV Department, World Health Organization, Geneva, Switzerland
    AIDS 20:1497-502. 2006
    ..To investigate the existence of national adult antiretroviral therapy (ART) guidelines in 43 World Health Organization (WHO) '3 by 5' focus countries and compare their content with the 2003 WHO ART guidelines...
  13. ncbi Are long-term non-progressors very slow progressors? Insights from the Chelsea and Westminster HIV cohort, 1988-2010
    Sundhiya Mandalia
    Department of Medicine, Imperial College London, Chelsea and Westminster Hospital, London, United Kingdom
    PLoS ONE 7:e29844. 2012
    ..Few LTNP and HIC identified in this and other studies, endorse the need for universal definitions to facilitate comparison...
  14. ncbi Cost-effectiveness of antenatal HIV-testing: reviewing its pharmaceutical and methodological aspects
    Maarten J Postma
    Groningen University
    Expert Opin Pharmacother 5:521-8. 2004
    ....
  15. ncbi The cost-effectiveness of highly active antiretroviral therapy, Canada 1991-2001
    Eduard J Beck
    Departement de sante publique de Montréal centre, Montreal, Quebec, Canada
    AIDS 18:2411-8. 2004
    ..To estimate the cost-effectiveness ratio of highly-active antiretroviral therapy (HAART) in Canada...
  16. ncbi Cost-effectiveness of highly active antiretroviral therapy in South Africa
    Motasim Badri
    Department of Medicine, Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa
    PLoS Med 3:e4. 2006
    ..Little information exists on the impact of highly active antiretroviral therapy (HAART) on health-care provision in South Africa despite increasing scale-up of access to HAART and gradual reduction in HAART prices...
  17. ncbi Cost and cost-effectiveness of antiretroviral therapy for HIV infection in Singapore
    Nicholas I Paton
    Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore
    Int J STD AIDS 17:699-705. 2006
    ..Dual ART therapy and HAART were cost-effective interventions in Singapore. Cost-effectiveness is likely to improve if drug prices continue to decrease...
  18. ncbi The economic profile of antenatal HIV testing: pharmaceutical and methodological considerations
    Maarten J Postma
    AIDS 17:755-7. 2003